Reported 27 days ago
Swiss stocks experienced a decline after the holiday due to concerns about US President Trump's 39% export tariff and increased pressure on drug companies to reduce prices. The Swiss Market Index fell by 1.9% before recovering to a 0.5% drop. Major pharmaceutical firms, Novartis and Roche, saw their shares decrease as US tariffs raised uncertainties about the pharmaceutical sector, despite their commitments to increasing investments in the US. The Swiss franc also weakened against the euro, reflecting ongoing economic anxieties.
Source: YAHOO